Number of the records: 1  

Prodrugs of prostate specific membrane antigen (PSMA) inhibitor

  1. SYS0559889
    LBL
      
    01000a^^22220027750^450
    005
      
    20240417124543.0
    100
      
    $a 20220810d m y slo 03 ba
    101
      
    $a eng $d eng
    200
    1-
    $a Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
    210
      
    $d 2022
    300
      
    $a PF:US9988407
    610
      
    $a 2-Phosphonomethylpentanedioic acid (2-PMPA)
    610
      
    $a glutamate carboxypeptidase II
    610
      
    $a GCPII
    610
      
    $a PSMA
    610
      
    $a pivaloyloxymethyl
    610
      
    $a isopropyloxycarbonyloxymethyl
    610
      
    $a POM
    610
      
    $a POC
    610
      
    $a prodrug
    700
    -1
    $3 cav_un_auth*0220054 $a Slusher $b B. $y US
    701
    -1
    $3 cav_un_auth*0302691 $a Rais $b R. $y US
    701
    -1
    $3 cav_un_auth*0103574 $a Krečmerová $b Marcela $p UOCHB-X $i Drug discovery $j Drug discovery $k 390/39 $l 390/39 $w Bioorganic and medicinal chemistry $y CZ $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0262294 $a Tichý $b Tomáš $p UOCHB-X $i Drug discovery $j Drug discovery $k 390/39 $l 390/39 $w Bioorganic and medicinal chemistry $y CZ $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0103597 $a Majer $b Pavel $p UOCHB-X $i Drug discovery $j Drug discovery $k 390/39 $l 390/39 $w Bioorganic and medicinal chemistry $y CZ $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0253283 $a Jančařík $b Andrej $p UOCHB-X $i Drug discovery $j Drug discovery $k 390/39 $l 390/39 $w Bioorganic and medicinal chemistry $y CZ $T Ústav organické chemie a biochemie AV ČR, v. v. i.
    856
      
    $u https://worldwide.espacenet.com/patent/search/family/055264571/publication/US11325931B2?q=US11325931B2 $9 RIV
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.